Phone app to help people with heart failure care for themselves after leaving hospital
Tests a self-care phone app in adults with heart failure going home.
Plain-language title generated from the registry record
Registry title: mHealth Intervention to Support Self-care During the Hospital to Home Transition in Individuals With Heart Failure
Key facts
- Where
- Bogotá, ColombiaSee the site
Where in Colombia
- Centro Cardiovascular Colombiano SASBogotá, ColombiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universidad de la Sabana
- Trial code
- NCT07478081
- Record updated
- 20 March 2026
- Original description
This study is a pilot randomized controlled trial designed to evaluate the feasibility, acceptability, usability, and preliminary efficacy of a mobile health (mHealth) educational self-management intervention for individuals with heart failure during the transition from hospital to home. Participants will be randomly assigned in a 1:1 ratio to receive either usual care alone or usual care plus the mHealth intervention.Read full original descriptionShow less
Evaluation of the Feasibility, Usability, and Preliminary Effects of an mHealth Intervention Complementary to Usual Care in Individuals With Heart Failure: Protocol for a Pilot Randomized Clinical Trial
This study is a pilot randomized controlled trial designed to evaluate the feasibility, acceptability, usability, and preliminary efficacy of a mobile health (mHealth) educational self-management intervention for individuals with heart failure during the transition from hospital to home. Participants will be randomly assigned in a 1:1 ratio to receive either usual care alone or usual care plus the mHealth intervention.
The mobile application is designed to support heart failure self-care through tailored educational content, symptom self-monitoring, automated feedback, behavioral reinforcement messages, caregiver involvement, and secure communication with the healthcare team. The application is educational in nature and does not replace standard medical treatment.
A total of 30 participants will be enrolled and followed for 60 days after hospital discharge, with outcome assessments conducted at 30 and 60 days. Primary outcomes focus on feasibility, technology acceptance, and usability of the intervention. Secondary exploratory outcomes include changes in self-care behaviors, functional status, heart failure related hospital readmissions and natriuretic peptide levels. Results from this pilot study will inform the design of a future definitive randomized controlled trial.
Inclusion: Age ≥ 18 years; Diagnosis of heart failure (NYHA Class II or III); Clinically stable at discharge (no IV inotropes within 48 hours; hemodynamically stable); Ownership of compatible smartphone (Android/iOS); Basic digital literacy; Availability of informal caregiver willing to support the process.
Exclusion: Severe cognitive impairment (MMSE <24 or documented dementia); Life expectancy < 6 months; Inability to provide informed consent; Participation in another interventional study.